According to an Axios report‚ new cancer diagnoses in the United States will eclipse two million for the first time in 2024. The outlet reports that the horrifying increase in cancers is driven by younger Americans. JUST IN – New cancer diagnoses expected to hit a record high in the U.S. this year‚ driven in large part by an alarming increase in cancers among younger Americans — Axios — Disclose.tv (@disclosetv) January 18‚ 2024 Chuck Callesto writes: New cancer diagnoses expected to HIT RECORD HIGH this year‚ driven in large part by an alarming increase in cancers among YOUNGER Americans.. WHAT COULD POSSIBLY BE CAUSING THIS? “New cancer diagnoses in the U.S. are expected to top 2 million for the first time in 2024‚ driven in large part by an alarming increase in cancers among younger Americans‚ according to new American Cancer Society data.” Axios BREAKING REPORT: New cancer diagnoses expected to HIT RECORD HIGH this year‚ driven in large part by an alarming increase in cancers among YOUNGER Americans.. WHAT COULD POSSIBLY BE CAUSING THIS? "New cancer diagnoses in the U.S. are expected to top 2 million for the first… pic.twitter.com/f2Zr0zw4qw — Chuck Callesto (@ChuckCallesto) January 18‚ 2024 X users made it abundantly clear what many people think has sparked the rise in cancer: Thanks‚ Covid vaccine! https://t.co/YcYhuGcyex — Candace Owens (@RealCandaceO) January 18‚ 2024 https://t.co/7nj6zsCof2 — Catturd (@catturd2) January 18‚ 2024 i wonder why this is happening https://t.co/DVcNhEghF0 — CCG BRYSON (@RealBrysonGray) January 18‚ 2024 Those that tried to warn this experimental mRNA would cause turbo cancers where censored‚ smeared ridiculed https://t.co/nIz429LDiM — As The World Turns (@Tumble_W33D) January 18‚ 2024 I’m going to say it out loud… C0VID VACCINES! Plans playing out is all… They need sick people! They will never want to cure anyone! #CashCows https://t.co/JhsVABeY2j — á—°EᒪᒪIE (@_mellieboo) January 18‚ 2024 Axios reports: There have been major improvements in cancer survival‚ but there’s a worrying rise in some cancers at the same time doctors are trying to figure out why they’re seeing more young patients with cancer. This demographic shift comes with psychological‚ physical and financial burdens that are less common with older patients‚ experts say. Patients under 50 are more likely to be uninsured‚ juggling career and caregiving responsibilities‚ and face a higher lifetime risk of treatment-related side effects like second cancers. “It’s overwhelming for anybody‚ but especially for these younger patients who are going on with their daily lives and then suddenly get this life-altering diagnosis and really don’t know where to turn‚” Robin Mendelsohn‚ co-director of the Center for Young Onset Colorectal and Gastrointestinal Cancers at Memorial Sloan Kettering‚ told Axios. “Many feel alone because they’re younger‚ their friends‚ many haven’t had to deal with this.” The proportion of people 65 and older diagnosed with cancer dropped from 61% to 58% in the last 30 years‚ even as the size of that group increased. The proportion of those diagnosed between ages 50-64 was largely stable. “Notably‚ people aged younger than 50 years were the only one of these three age groups to experience an increase in overall cancer incidence during this time period‚” the ACS report said. Doctors don’t know exactly what’s behind the uptick in new cases and deaths among younger patients in many cases. Pharmaceutical companies are ready to profit off this alarming cancer rise. Johnson &; Johnson paid $2 billion in cash to acquire Ambrx Biopharma‚ a company specializing in cancer treatment. Johnson &; Johnson Makes $2 Billion Purchase For Drugmaker Specializing In Cancer Treatment Pfizer acquired Seagen Inc.‚ a global biotechnology company that discovers‚ develops and commercializes transformative cancer medicines. Pfizer Established As “Leading Oncology Company” After $43 Billion Purchase “Pfizer completed its acquisition of all outstanding common stock of Seagen for $229 in cash per share‚ for a total enterprise value of approximately $43 billion‚” Pfizer said in a press release. According to the press release‚ the acquisition “further establishes Pfizer as a leading oncology company poised to accelerate the next generation of breakthrough treatments for people with cancer.” “Cancer remains a leading cause of death‚ and one in three people in the U.S. will receive a cancer diagnosis in their lifetime. With one of the largest investments in Pfizer’s history‚ we are going all in on cancer with the goal of delivering breakthroughs that drastically improve the lives of people with cancer‚” said Dr. Albert Bourla‚ Pfizer Chairman and Chief Executive Officer. “With Seagen’s proprietary‚ world-leading Antibody-Drug Conjugate (ADC) technology‚ together with the scale and strength of Pfizer’s capabilities and expertise‚ we are poised to change the cancer treatment paradigm. We believe Oncology will be a significant growth driver for Pfizer and contribute meaningfully to the achievement of our near- and long-term financial goals‚” he added. Pfizer completed its acquisition of all outstanding common stock of Seagen for $229 in cash per share‚ for a total enterprise value of approximately $43 billion. “Cancer remains a leading cause of death‚ and one in three people in the U.S. will receive a cancer diagnosis in… pic.twitter.com/9LIvN4w1PS — Dr. Kat Lindley (@KLVeritas) December 16‚ 2023 “Johnson &; Johnson to acquire $2 billion drug developer ‘Ambrx Biopharma’ to treat Turbo Cancers with same tech as Pfizer’s $43 billion Seagen acquisition. Both set their sights on 2025 Cancer TSUNAMI‚” Dr. William Makis writes. “Pfizer &; Moderna COVID-19 mRNA Vaccines cause Turbo Cancers‚ this is now well acknowledged by respected physicians around the world. Last month‚ Pfizer closed a $43 billion acquisition of Seagen‚ to boost its ability to treat 7 of the top 10 Turbo Cancers caused by its COVID-19 mRNA Vaccine‚” he added. NEW ARTICLE: Johnson &; Johnson to acquire $2 billion drug developer "Ambrx Biopharma" to treat Turbo Cancers with same tech as Pfizer's $43 billion Seagen acquisition. Both set their sights on 2025 Cancer TSUNAMI Pfizer &; Moderna COVID-19 mRNA Vaccines cause Turbo Cancers‚ this… pic.twitter.com/Ehl9UvXl8s — William Makis MD (@MakisMD) January 17‚ 2024 Makis writes: Top 5 Turbo Cancers: lymphoma‚ glioblastoma‚ breast‚ colon‚ lung Top 10 Turbo Cancers: leukemia‚ melanoma‚ sarcomas‚ testicular/ovarian‚ kidney Pfizer expects a “Cancer Tsunami” to hit in 2025 Moderna is rushing its melanoma mRNA Cancer vaccine to have expedited approval by 2025. Johnson &; Johnson is the latest to want a piece of the Turbo Cancer treatment pie before 2025. This $2 billion acquisition of Ambrx Biopharma gives them the same cancer treatment tech as Pfizer – ADCs. ADC: “a class of therapeutics that combines the specificity of monoclonal antibodies with the potency of cytotoxic drugs‚ aiming to target and destroy cancer cells more effectively” Johnson &; Johnson‚ for $2 billion‚ adds new ability to treat Breast Turbo Cancer‚ Prostate Turbo Cancer and Kidney Turbo Cancer with this acquisition. They also overpaid by more than 100% of the current Ambrx Biopharma stock price. Acquisition expected to close in mid 2024. Many pharmaceutical companies are rushing to position themselves to profit from treating a tsunami of cancers that they are all expecting to hit starting in 2025. Dec.14‚ 2023 – Pfizer closed a $43 billion acquisition to treat several turbo cancers and expects to “fill a gap” for the period 2025-2030. Dec.14‚ 2023 – Moderna targets new mRNA Cancer vaccine to treat melanoma to be available by 2025 Jan.8‚ 2024 – Johnson &; Johnson to acquire $2 billion cancer drug company that uses same tech as Pfizer‚ to “fill a revenue gap starting in 2025” Jan.10‚ 2024 – BioNTech expects to return to revenue growth in 2025‚ when its COVID vaccine business would bottom out‚ and it would invest to “scale up its oncology business thereafter” Many companies that have new blood tests or light tests to quickly detect cancer are all targeting 2025 for their launch. I provide examples. Dozens of giant Cancer Centers are going up all across the US‚ Canada‚ Australia and UK – all of them are opening in 2025. They’re ready for the 2025 Cancer TSUNAMI. Are you? Read more about ‘Turbo Cancer‘: The Truth Behind “Turbo Cancer”